Senators ask FDA to use different approval process for biotech salmon

09/29/2010 | Washington Post, The

Sen. Mark Begich, D-Alaska, and 10 other senators wrote a letter to FDA Commissioner Margaret Hamburg, saying the agency should stop reviewing the approval application for a biotech Atlantic salmon, AquAdvantage. They claim the FDA is handling the process as if it were for approval of a veterinary drug, not a new animal meant for human consumption.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX